Dermbits

Dermbits

Welcome to Dermbits! Watch short videos of KOLs answering your questions
What advancements in the understanding of actinic keratosis pathophysiology or treatment are shaping future management approaches?
2:00
Oct 17, 2025Actinic Keratosis

What advancements in the understanding of actinic keratosis pathophysiology or treatment are shaping future management approaches?

-

Is home-based NB-UVB a challenge to prescribe for clinicians?
0:26
Oct 13, 2025NB-UVB

Is home-based NB-UVB a challenge to prescribe for clinicians?

-

What practical steps can a dermatologist take to start prescribing a home-based NB-UVB device?
0:48
Oct 13, 2025NB-UVB

What practical steps can a dermatologist take to start prescribing a home-based NB-UVB device?

-

What are the key benefits of home-based NB-UVB devices?
1:17
Oct 13, 2025NB-UVB

What are the key benefits of home-based NB-UVB devices?

-

Is home-based NB-UVB better suited for localized disease or widespread conditions?
1:01
Oct 13, 2025NB-UVB

Is home-based NB-UVB better suited for localized disease or widespread conditions?

-

Is home-based NB-UVB device setup difficult for patients?
1:01
Oct 13, 2025NB-UVB

Is home-based NB-UVB device setup difficult for patients?

-

How does guided dosing mode on newer devices improve safety and reduce uncertainty for both patients and dermatologists?
0:48
Oct 13, 2025NB-UVB

How does guided dosing mode on newer devices improve safety and reduce uncertainty for both patients and dermatologists?

-

How straightforward is the prescribing and enrollment process for at-home phototherapy?
0:24
Oct 13, 2025NB-UVB

How straightforward is the prescribing and enrollment process for at-home phototherapy?

-

Why has phototherapy declined in use, and are the main barriers clinical or logistical?
2:06
Oct 13, 2025NB-UVB

Why has phototherapy declined in use, and are the main barriers clinical or logistical?

-

What practical considerations should dermatologists keep in mind when setting up a patient with an at-home phototherapy unit?
1:37
Oct 13, 2025NB-UVB

What practical considerations should dermatologists keep in mind when setting up a patient with an at-home phototherapy unit?

-

What kind of clearance rates can be expected in psoriasis with NB-UVB phototherapy?
1:29
Oct 13, 2025NB-UVB

What kind of clearance rates can be expected in psoriasis with NB-UVB phototherapy?

-

What differentiates IL-13 from IL-4 in the progression of AD?
1:22
Oct 1, 2025Atopic Dermatitis

What differentiates IL-13 from IL-4 in the progression of AD?

-

How do you identify and manage itch-dominant AD patients?
1:57
Oct 1, 2025Atopic Dermatitis

How do you identify and manage itch-dominant AD patients?

-

How can dermatologists more effectively measure and monitor treatment success beyond traditional scaling/scoring tools?
2:15
Oct 1, 2025Atopic Dermatitis

How can dermatologists more effectively measure and monitor treatment success beyond traditional scaling/scoring tools?

-

What role does proactive vs reactive therapy play in maintaining long-term disease control in AD?
1:34
Oct 1, 2025Atopic Dermatitis

What role does proactive vs reactive therapy play in maintaining long-term disease control in AD?

-

What factors can help dermatologists determine which cytokine pathway to target when selecting a therapy for AD?
2:58
Oct 1, 2025Atopic Dermatitis

What factors can help dermatologists determine which cytokine pathway to target when selecting a therapy for AD?

-

What are the long-term impacts of early-onset AD on child development and overall health?
1:38
Oct 1, 2025Atopic Dermatitis

What are the long-term impacts of early-onset AD on child development and overall health?

-

Should patients with moderate AD by treated with systemic therapies earlier in disease progression?
2:11
Oct 1, 2025Atopic Dermatitis

Should patients with moderate AD by treated with systemic therapies earlier in disease progression?

-

How can dermatologists identify and manage treatment resistance in patients with AD?
2:56
Oct 1, 2025Atopic Dermatitis

How can dermatologists identify and manage treatment resistance in patients with AD?

-

What are the most effective ways to communicate realistic treatment expectations to patients with AD?
2:17
Oct 1, 2025Atopic Dermatitis

What are the most effective ways to communicate realistic treatment expectations to patients with AD?

-

What challenges exist in assessing AD in patients with skin of color, and how can they be addressed?
2:35
Oct 1, 2025Atopic Dermatitis

What challenges exist in assessing AD in patients with skin of color, and how can they be addressed?

-

Do patients need to demonstrate inadequate response to topical therapies before initiating lebrikizumab?
1:08
Oct 1, 2025Atopic Dermatitis

Do patients need to demonstrate inadequate response to topical therapies before initiating lebrikizumab?

-

Why is systemic therapy for atopic dermatitis still underutilized, despite the availability of newer targeted options?
1:43
Oct 1, 2025Atopic Dermatitis

Why is systemic therapy for atopic dermatitis still underutilized, despite the availability of newer targeted options?

-

How can dermatologists improve diagnostic accuracy for AD in skin of color?
2:19
Oct 1, 2025Atopic Dermatitis

How can dermatologists improve diagnostic accuracy for AD in skin of color?

-